Literature DB >> 1623641

The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.

A E Kabakov1, V V Tertov, V A Saenko, A M Poverenny, A N Orekhov.   

Abstract

The influence of systemic lupus erythematosus (SLE) patients' sera on lipid accumulation in the cultured smooth muscle cells (SMC) from unaffected human aortic intima was examined. It was demonstrated that the cholesterol uptake in the SMC cultured in the presence of SLE sera is 1.5- to 6-fold higher than in the cells cultured with normal human sera (NHS) obtained from healthy donors. Incubation of the SMC with circulating immune complexes (CIC) isolated from lupus sera by precipitation with 2.5% polyethylene glycol 6000 (PEG) caused a 3- to 4-fold rise in the intracellular cholesterol level. The atherogenic effect of lupus sera, as well as isolated CIC, strongly correlated (r = 0.98) with the low density lipoprotein (LDL) content in the PEG-precipitated CIC. The cholesterol level in cultured SMC also increased 2- to 3-fold when growth medium was supplemented with LDL, DNA, and anti-DNA autoantibodies (IgG) affinity isolated from lupus sera. Using immunofluorescent staining, it was shown that the addition of a DNA-anti-DNA IgG mixture to the growth medium, together with NHS, stimulated LDL incorporation in the SMC. The results of double-label staining suggest the formation of LDL-DNA-IgG complexes which seem to be entrapped in cells more actively than free LDL. The composition of PEG-precipitated CIC was studied by electrophoresis and immunoblotting. Significant amounts of apolipoprotein B, as well as low molecular weight DNA and immunoglobulins, were found in SLE-derived CIC. The data obtained suggest that the atherogenic effect of human lupus sera in vitro is generally due to the appearance of LDL-containing immune complexes. Different mechanisms possibly involved in the lupus atherogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623641     DOI: 10.1016/0090-1229(92)90225-d

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

Review 1.  Association of anticardiolipin antibodies with vascular injury: possible mechanisms.

Authors:  Y S Haviv
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  [Cardiovascular manifestations in inflammatory rheumatic diseases].

Authors:  U Lange; J Strunk
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

3.  Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography.

Authors:  C A Roldan; J Joson; C R Qualls; J Sharrar; W L Sibbitt
Journal:  Lupus       Date:  2010-09-02       Impact factor: 2.911

Review 4.  Atherosclerosis and systemic lupus erythematosus.

Authors:  M Urowitz; D Gladman; I Bruce
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

5.  Food restriction and fish oil suppress atherogenic risk factors in lupus-prone (NZB x NZW) F1 mice.

Authors:  Alagarraju Muthukumar; Khaliquz Zaman; Richard Lawrence; Jeffery L Barnes; Gabriel Fernandes
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

Review 6.  Intravenous thrombolysis in SLE-related stroke: a case report and literature review.

Authors:  Xiaodong Chen; Gelin Xu
Journal:  Neurol Sci       Date:  2017-11-07       Impact factor: 3.307

Review 7.  Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.

Authors:  Allison B Reiss
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

8.  Atherosclerotic vascular disease in systemic lupus erythematosus.

Authors:  Matthew H Liang; Lisa A Mandl; Karen Costenbader; Ervin Fox; Elizabeth Karlson
Journal:  J Natl Med Assoc       Date:  2002-09       Impact factor: 1.798

9.  Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.

Authors:  Allison B Reiss; Kamran Anwar; Joan T Merrill; Edwin S L Chan; Nahel W Awadallah; Bruce N Cronstein; H Michael Belmont; Elise Belilos; Gary Rosenblum; Kristina Belostocki; Lois Bonetti; Kowser Hasneen; Steven E Carsons
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

10.  Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus.

Authors:  Qingjun Pan; Li Gong; Haiyan Xiao; Yongmin Feng; Lu Li; Zhenzhen Deng; Ling Ye; Jian Zheng; Carol A Dickerson; Lin Ye; Ning An; Chen Yang; Hua-Feng Liu
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.